JP2024519668A5 - - Google Patents
Info
- Publication number
- JP2024519668A5 JP2024519668A5 JP2023562806A JP2023562806A JP2024519668A5 JP 2024519668 A5 JP2024519668 A5 JP 2024519668A5 JP 2023562806 A JP2023562806 A JP 2023562806A JP 2023562806 A JP2023562806 A JP 2023562806A JP 2024519668 A5 JP2024519668 A5 JP 2024519668A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutical composition
- dendrimer
- cancer
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163174878P | 2021-04-14 | 2021-04-14 | |
| US63/174,878 | 2021-04-14 | ||
| PCT/US2022/024752 WO2022221490A1 (en) | 2021-04-14 | 2022-04-14 | Dendrimer-glutamine antagonist conjugates and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519668A JP2024519668A (ja) | 2024-05-21 |
| JP2024519668A5 true JP2024519668A5 (cg-RX-API-DMAC7.html) | 2025-04-16 |
Family
ID=83640697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562806A Pending JP2024519668A (ja) | 2021-04-14 | 2022-04-14 | デンドリマー-グルタミンアンタゴニストコンジュゲートおよびそれを使用する方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240398962A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4322961A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024519668A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022221490A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024151843A1 (en) * | 2023-01-11 | 2024-07-18 | The Johns Hopkins University | Targeted universal delivery system of don and other drugs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20231163T1 (hr) * | 2015-07-31 | 2024-03-15 | The Johns Hopkins University | Prolijekovi glutaminskih analoga |
| US10842763B2 (en) * | 2015-07-31 | 2020-11-24 | The Johns Hopkins University | Methods for cancer and immunotherapy using prodrugs of glutamine analogs |
-
2022
- 2022-04-14 EP EP22788909.4A patent/EP4322961A4/en active Pending
- 2022-04-14 US US18/554,946 patent/US20240398962A1/en active Pending
- 2022-04-14 JP JP2023562806A patent/JP2024519668A/ja active Pending
- 2022-04-14 WO PCT/US2022/024752 patent/WO2022221490A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101420963B (zh) | 用于治疗乳腺癌、结肠直肠癌、胰腺癌、卵巢癌和肺癌的7-乙基-10-羟基喜树碱的多臂聚合轭合物 | |
| CN112245591B (zh) | 化疗药物-低氧激活前药一体化前药自组装纳米粒的构建 | |
| CN101605539B (zh) | 用7-乙基-10-羟基喜树碱的多臂聚合缀合物治疗抵抗性或顽固性癌症 | |
| JP7588065B2 (ja) | 治療用デンドリマー | |
| CN107708702A (zh) | 磷脂醚类似物作为靶向癌症的药物载体 | |
| JP2003509386A (ja) | タキサン・プロドラッグ | |
| JP2010503691A (ja) | 7‐エチル‐10‐ヒドロキシカンプトセシンのマルチアームポリマー複合体を用いた非ホジキンリンパ腫の治療方法 | |
| CN102215688A (zh) | 用7-乙基-10-羟基喜树碱的多臂聚合物对神经母细胞瘤的治疗 | |
| CN110092775B (zh) | 靶向cdk4/6激酶抑制剂的晶型 | |
| JP2010043114A (ja) | 腫瘍転移および癌の治療 | |
| CN111484501A (zh) | 羟基喜树碱亚油酸酯小分子前药及其自组装纳米粒的构建 | |
| CN111671771B (zh) | 靶向dna大沟并抑制拓扑异构酶的石墨烯碱及其制法和用途 | |
| JP7506659B2 (ja) | 癌を処置する方法に用いられるコンジュゲート | |
| JP2022544559A5 (cg-RX-API-DMAC7.html) | ||
| TW202110448A (zh) | Parp抑制劑聯合vegfr抑制劑用於治療卵巢癌或乳腺癌的用途 | |
| CN117396227A (zh) | siRNA递送载体 | |
| CN101466387A (zh) | 镓(ⅲ)络合物在黑素瘤治疗中的应用 | |
| JP2021518336A (ja) | 上咽頭がん治療用キノリン誘導体 | |
| JP7506660B2 (ja) | デンドリマー製剤 | |
| CN110698491B (zh) | 2-(喜树碱-10-氧基)乙酰胺类化合物和应用 | |
| CN117017947B (zh) | 一种肿瘤细胞膜包被富勒烯的纳米材料及其制备方法和应用 | |
| RU2697551C2 (ru) | Новые производные peg | |
| CN116327782B (zh) | 一种骨靶向共递送硼替佐米和泊马度胺纳米复合物及其制备方法和应用 | |
| CN101830819A (zh) | 苯丁酰基姜黄素衍生物及其在制备抗肿瘤药物中的应用 | |
| CN121991143A (zh) | 一种2-乙酰氨基葡萄糖硫酸钾盐及其制备方法与应用 |